Disrupting Hepatocyte Cyp51 from Cholesterol Synthesis Leads to Progressive Liver Injury in the Developing Mouse and Decreases RORC Signalling. - Wikidata - awgldk - TriplyDB

Disrupting Hepatocyte Cyp51 from Cholesterol Synthesis Leads to Progressive Liver Injury in the Developing Mouse and Decreases RORC Signalling.

Disrupting Hepatocyte Cyp51 from Cholesterol Synthesis Leads to Progressive Liver Injury in the Developing Mouse and Decreases RORC Signalling.

http://www.wikidata.org/entity/Q37591214

about

Evaluation of Selected CYP51A1 Polymorphisms in View of Interactions with Substrate and Redox Partner.LiverSex Computational Model: Sexual Aspects in Hepatic Metabolism and Abnormalities.

P2860

Q33857035-4907EE2B-D6AA-49D0-AC2B-F3F27BB46405 Q55192876-451B8550-56F8-4E46-9790-2AA7E6F1EC13

P2860

Disrupting Hepatocyte Cyp51 from Cholesterol Synthesis Leads to Progressive Liver Injury in the Developing Mouse and Decreases RORC Signalling.

http://www.wikidata.org/entity/Q37591214

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 January 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Disrupting Hepatocyte Cyp51 fr ...... and Decreases RORC Signalling.

@en

Disrupting Hepatocyte Cyp51 fr ...... and Decreases RORC Signalling.

@nl

type

label

Disrupting Hepatocyte Cyp51 fr ...... and Decreases RORC Signalling.

@en

Disrupting Hepatocyte Cyp51 fr ...... and Decreases RORC Signalling.

@nl

prefLabel

Disrupting Hepatocyte Cyp51 fr ...... and Decreases RORC Signalling.

@en

Disrupting Hepatocyte Cyp51 fr ...... and Decreases RORC Signalling.

@nl

P1433

Q37591214-F7B5D97C-B4C6-4B0B-BFE5-03DE69772750

P1476

Q37591214-07E3C808-3558-4007-B97C-E5D3BD29B5E5

P2093

Q37591214-067FA2D2-CCAD-4176-8C8B-E71F86F50A69

Q37591214-0B00A052-94C9-4E1A-94C9-5C42CDE7EB1C

Q37591214-1195B207-BD03-4BAB-8F97-AD5B6F74E9C6

Q37591214-25307C3D-550F-403D-B322-A779A3939D4C

Q37591214-51F2C302-EEB6-437A-A941-0F33CFAD80F7

Q37591214-68608928-5068-42AE-A7DC-F209F3BF17CF

Q37591214-B342BF27-4884-4DE0-9143-BF0D37997136

Q37591214-BF826C69-EE2D-4295-9154-906CD2B380E9

Q37591214-C8C9913E-E4EC-4C69-8451-D5D9C0973569

Q37591214-DF9FE177-ABE0-4225-BAA1-3CC64F573CAC

P2860

Q37591214-01E45F47-BA7B-4AAB-B57C-CA4100EEFE6D

Q37591214-02309437-28BA-45D4-B760-94FFCD32153C

Q37591214-0DF6B464-B556-46D1-8E5B-5C4541A48EFD

Q37591214-12A7C42C-03FC-4774-931F-BF85AB7A67B7

Q37591214-169E962D-F0FB-498E-8B36-1D5385DAA2B5

Q37591214-23399B96-6045-4D5F-A0A3-273EAC240E9B

Q37591214-28A48862-FD9A-4030-BEBB-DB18D4937575

Q37591214-2DDA1B66-1424-4DF3-AF1F-C99366A91E93

Q37591214-32BCA07B-4AEE-4976-B781-D65E693352CE

Q37591214-3CB95E5F-3EAE-4CE1-97E7-5D67ACEAB932

P2888

Q37591214-0BFDC2F9-C103-4361-9B27-9C68219BBB8F

P304

Q37591214-08763748-0032-4608-BCE9-BB8C8BC95893

P31

Q37591214-1E297E31-71B4-49B3-9DE4-27C028666230

P356

Q37591214-B07B5AC5-5478-49F3-894E-5004A4E66DBD

P407

Q37591214-E6DDC818-2207-4D68-9511-54459914A2A8

P478

Q37591214-32E667D1-E517-44B4-9EE7-EA3F6ADD59EC

P50

Q37591214-CED1F99F-7E73-4F1D-A2E5-776E08D1CB05

Q37591214-F555EB39-2EAF-4390-9186-C06801F7071B

P577

Q37591214-B5125E68-9566-4F23-B66A-69427FAB7331

P698

Q37591214-33B8C585-3D33-42F2-BAA0-EE110691A264

P932

Q37591214-385B1D28-6CEC-40E5-B81B-1AFC8D47640F

P356

P1433

Scientific Reports

P1476

Disrupting Hepatocyte Cyp51 fr ...... and Decreases RORC Signalling.

@en

P2093

Damjana Rozman

http://www.w3.org/2001/XMLSchema#string

Dan R Littman

http://www.w3.org/2001/XMLSchema#string

Gregor Lorbek

http://www.w3.org/2001/XMLSchema#string

Jason A Hall

http://www.w3.org/2001/XMLSchema#string

Jera Jeruc

http://www.w3.org/2001/XMLSchema#string

Martina Perše

http://www.w3.org/2001/XMLSchema#string

Peter Juvan

http://www.w3.org/2001/XMLSchema#string

Richard Bonneau

http://www.w3.org/2001/XMLSchema#string

Rolf Gebhardt

http://www.w3.org/2001/XMLSchema#string

Žiga Urlep

http://www.w3.org/2001/XMLSchema#string

P2860

REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis

Identification of a nuclear receptor for bile acids

ROR gamma: the third member of ROR/RZR orphan receptor subfamily that is highly expressed in skeletal muscle

Endoplasmic reticulum stress-induced formation of transcription factor complex ERSF including NF-Y (CBF) and activating transcription factors 6alpha and 6beta that activates the mammalian unfolded protein response

Retinoid-related orphan receptor gamma (RORgamma) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis

RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells

Hidden disease susceptibility and sexual dimorphism in the heterozygous knockout of Cyp51 from cholesterol synthesis

Cytochrome P450 metabolism of the post-lanosterol intermediates explains enigmas of cholesterol synthesis.

Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A

Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists

P2888

P304

40775

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP40775

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Ingemar Björkhem

Madlen Matz-Soja

P577

2017-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28098217

http://www.w3.org/2001/XMLSchema#string

P932

5241696

http://www.w3.org/2001/XMLSchema#string